Loader

Pathways

PathWhiz ID Pathway Meta Data

PW127854

Pw127854 View Pathway
drug action

Procainamide Action Pathway (New)

Homo sapiens
Procainamide is a class 1A antidysrythmIc as well as an anesthetic that is used to treat ventricular dysrhythmias, tachycardia and atrial fibrillation. Procainamide mainly inhibits sodium channels protein type 5 subunit alpha but also inhibits the potassium voltage gated channel subfamily H member 2. The main antidysrythmIc effect is mediated through the sodium channel blockage though. Phenytoin slows the rate of rise in the pacemaker potential and shortens the plateau phase of atrial and ventricular myocytes as well as purkinje fibre cells as they have 'fast' action potential. This converts a one way block into a two block effectively stopping the circus rhythm irregularity. Procainamide works through use-dependent blockage meaning that it preferentially binds to the inactivate state of the sodium channel. The more active the channel the more chances procainamide can bind to the channel and block it. Procainamide can be administered through either oral or intravenous routes with both having a relatively short half-life of 2.5 to 4.5 hours. Some side effects of using procainamide may include cardiac toxicity, bradycardia, hypotension, drug-induced lupus erythematosus-like syndrome, and blood dyscrasias.

PW145131

Pw145131 View Pathway
drug action

Procainamide Drug Metabolism Action Pathway

Homo sapiens

PW126022

Pw126022 View Pathway
drug action

Procainamide Mechanism of Action

Homo sapiens
Procainamide is a class 1A antidysrythmIc as well as an anesthetic that is used to treat ventricular dysrhythmias, tachycardia and atrial fibrillation. Procainamide mainly inhibits sodium channels protein type 5 subunit alpha but also inhibits the potassium voltage gated channel subfamily H member 2. The main antidysrythmIc effect is mediated through the sodium channel blockage though. Phenytoin slows the rate of rise in the pacemaker potential and shortens the plateau phase of atrial and ventricular myocytes as well as purkinje fibre cells as they have 'fast' action potential. This converts a one way block into a two block effectively stopping the circus rhythm irregularity. Procainamide works through use-dependent blockage meaning that it preferentially binds to the inactivate state of the sodium channel. The more active the channel the more chances procainamide can bind to the channel and block it. Procainamide can be administered through either oral or intravenous routes with both having a relatively short half-life of 2.5 to 4.5 hours

PW124505

Pw124505 View Pathway
metabolic

Procainamide metabolic pathway

Homo sapiens

PW126561

Pw126561 View Pathway
drug action

Procaine

Homo sapiens
Procaine is an anesthetic used mainly for peripheral and spinal nerve block, it is an ester with slow onset and short duration of action, used mainly for oral surgery. Procaine has the additional effect of constricting blood vessels to reduce bleeding. It is metabolized in the plasma by pseudocholinesterase by the process of hydrolysis into para-aminobenzoic acid (PABA) when is excreted through the process of diuresis. It's mechanism of action in mainly by inhibiting sodium flux through voltage gated sodium channels, due to this an action potential cannot be conducted. It binds to the receptor site in the cytoplasmic portion of the sodium channel, it also antagonizes N-methyl-D-aspartate (NMDA), nicotinic acetylcholine and serotonin receptors.

PW000408

Pw000408 View Pathway
drug action

Procaine Action Pathway

Homo sapiens
Procaine exerts its local anaesthetic effect by blocking voltage-gated sodium channels in peripheral neurons. Procaine diffuses across the neuronal plasma membrane in its uncharged base form. Once inside the cytoplasm, it is protonated and this protonated form enters and blocks the pore of the voltage-gated sodium channel from the cytoplasmic side. For this to happen, the sodium channel must first become active so that so that gating mechanism is in the open state. Therefore procaine preferentially inhibits neurons that are actively firing.

PW132329

Pw132329 View Pathway
metabolic

Procaine benzylpenicillin Drug Metabolism

Homo sapiens
Procaine benzylpenicillin is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Procaine benzylpenicillin passes through the liver and is then excreted from the body mainly through the kidney.

PW144833

Pw144833 View Pathway
drug action

Procaine Drug Metabolism Action Pathway

Homo sapiens

PW132257

Pw132257 View Pathway
metabolic

Procaine merethoxylline Drug Metabolism

Homo sapiens
Procaine merethoxylline is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Procaine merethoxylline passes through the liver and is then excreted from the body mainly through the kidney.

PW146113

Pw146113 View Pathway
drug action

Procaine merethoxylline Drug Metabolism Action Pathway

Homo sapiens